89 results
10-K
2020 FY
EX-4.2
MRVI
Maravai LifeSciences Holdings Inc - Ordinary Shares
22 Mar 21
Annual report
4:22pm
as the exclusive forum for certain litigation, including any “derivative action,” does not apply to suits to enforce a duty or liability created … ;
the provision establishing the Court of Chancery of the State of Delaware as the exclusive forum for certain litigation;
the provision establishing the federal
DRSLTR
MRVI
Maravai LifeSciences Holdings Inc - Ordinary Shares
23 Oct 20
Correspondence regarding draft registration statement
12:00am
of the Court of Chancery of Delaware as the exclusive forum for the noted litigation matters.
Response
In response to the Staff’s comment … of Chancery of Delaware as the exclusive forum for the noted litigation matters.
Securities and Exchange Commission
October 23, 2020
Page 4
8-K
EX-99.1
MRVI
Maravai LifeSciences Holdings Inc - Ordinary Shares
19 Oct 22
Departure of Directors or Certain Officers
4:05pm
Exhibit 99.1
Maravai LifeSciences Temporarily Reinstates Carl Hull as CEO Amidst Pending Noncompetition Litigation
Maravai LifeSciences
UPLOAD
MRVI
Maravai LifeSciences Holdings Inc - Ordinary Shares
21 Oct 20
Letter from SEC
12:00am
as a result of the selection
of the Court of
Chancery of Delaware as the exclusive forum for the noted litigation
matters.
Management Discussion
10-K
6eo94gl 09yyur2q
22 Mar 21
Annual report
4:22pm
DRS
mpn4csda 6rjdq3aa
8 Sep 20
Draft registration statement
12:00am
S-1
rm16eb ib
29 Oct 20
IPO registration
5:04pm
424B4
gmr8tgn48te3sd6wj3
23 Nov 20
Prospectus supplement with pricing info
4:36pm
DRS/A
cquqnk m8zeob
14 Oct 20
Draft registration statement (amended)
12:00am
DRS/A
nn0zdvr0202 hesie
23 Oct 20
Draft registration statement (amended)
12:00am
8-K
EX-99.1
ewqpez s9vqqvlq2y
27 Jul 23
Maravai LifeSciences Announces Completion of Planned CEO Leadership Transition
4:11pm
8-K
EX-99.1
26f32yw oaqd2j
1 Dec 22
Maravai LifeSciences Announces Updated CEO Leadership Transition Plans
4:26pm
8-K
EX-99.1
6ks06m90e
20 Jul 23
Maravai LifeSciences Announces Appointment of New Director to the Board
4:08pm
8-K
EX-99.1
pgomeoszw ntg
3 Oct 22
Maravai LifeSciences Announces CEO Leadership Transition
4:07pm
8-K
EX-99.1
igzlzvqayja6ob eo
28 Jan 22
Maravai LifeSciences Acquires MyChem, a Leader in Proprietary Ultra-Pure Nucleotides
8:03am
8-K
EX-99.1
ty62zcyng9us
5 Apr 21
Maravai Lifesciences Announces Preliminary Unaudited First Quarter Revenues and Income from Operations Range
5:15pm
424B4
6f74jynb ptl0up3
13 Sep 21
Prospectus supplement with pricing info
4:16pm